Healing Touch Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 22-12-2024
- Paid Up Capital ₹ 1.00 M
as on 22-12-2024
- Company Age 17 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 2.50 M
as on 22-12-2024
- Revenue %
(FY 2022)
- Ebitda
- Net Worth 4.42%
(FY 2022)
- Total Assets 1.00%
(FY 2022)
About Healing Touch Pharma
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company has closed loans amounting to ₹2.50 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Kapil Seth and Preeti Seth serve as directors at the Company.
- CIN/LLPIN
U93030DL2007PTC158749
- Company No.
158749
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Feb 2007
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Healing Touch Pharma Private Limited offer?
Healing Touch Pharma Private Limited offers a wide range of products and services, including Mobile Spare Parts, Mobile Touch Screen, Medical Consultancy Services, Embryo Donation, Veterinary Medicines, Veterinary Bolus, Antacid Drugs, Allopathic Liver Tonic.
Who are the key members and board of directors at Healing Touch Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kapil Seth  | Director | 03-Feb-2007 | Current |
| Preeti Seth | Director | 16-Jul-2012 | Current |
Financial Performance of Healing Touch Pharma.
Healing Touch Pharma Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth moved up by a moderate rise of 4.42%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Healing Touch Pharma?
In 2017, Healing Touch Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Punjab National Bank Creation Date: 02 Nov 2012 | ₹2.50 M | Satisfied |
How Many Employees Work at Healing Touch Pharma?
Unlock and access historical data on people associated with Healing Touch Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Healing Touch Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Healing Touch Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
